Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease

Neurobiol Aging. 2010 Jan;31(1):162-4. doi: 10.1016/j.neurobiolaging.2008.03.005. Epub 2008 Apr 22.

Abstract

In our case-control study we analyzed two functional IL18 gene promoter polymorphisms (-137G/C and -607C/A) and an additional polymorphism at position -656 (G/T) in Alzheimer patients and healthy controls in order to verify the involvement of these genetic variations in the onset of Alzheimer disease. No significant differences were detected for the three IL18 SNPs between AD patients and controls. The haplotypes distribution also did not show any difference within AD subjects and controls.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / physiopathology
  • Biomarkers
  • Case-Control Studies
  • DNA Mutational Analysis
  • Gene Frequency / genetics
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Interleukin-18 / genetics*
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic / genetics*

Substances

  • Biomarkers
  • Genetic Markers
  • Interleukin-18